These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26921596)

  • 21. Retigabine, a K(V)7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats.
    Sander SE; Lemm C; Lange N; Hamann M; Richter A
    Neuropharmacology; 2012 Feb; 62(2):1052-61. PubMed ID: 22079161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems.
    Dessens AB; Cohen-Kettenis PT; Mellenbergh GJ; Koppe JG; van De Poll NE; Boer K
    Acta Paediatr; 2000 May; 89(5):533-41. PubMed ID: 10852187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent exposure to aluminum and stress during pregnancy in rats: Effects on postnatal development and behavior of the offspring.
    Colomina MT; Roig JL; Torrente M; Vicens P; Domingo JL
    Neurotoxicol Teratol; 2005; 27(4):565-74. PubMed ID: 16024221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder.
    Rode F; Svalø J; Sheykhzade M; Rønn LC
    Eur J Pharmacol; 2010 Jul; 638(1-3):121-7. PubMed ID: 20385123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced adverse effects of prenatal exposure to silver nanoparticles on neurobehavioral development of offspring of mice.
    Ghaderi S; Tabatabaei SR; Varzi HN; Rashno M
    J Toxicol Sci; 2015 Apr; 40(2):263-75. PubMed ID: 25786530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies.
    Gil-Nagel A; Brodie MJ; Leroy R; Cyr T; Hall S; Castiglia M; Twomey C; VanLandingham K
    Epilepsy Res; 2012 Nov; 102(1-2):117-21. PubMed ID: 22771137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retigabine: fewer drug interactions.
    Prescrire Int; 2012 Mar; 21(125):61. PubMed ID: 22428181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retigabine: chemical synthesis to clinical application.
    Blackburn-Munro G; Dalby-Brown W; Mirza NR; Mikkelsen JD; Blackburn-Munro RE
    CNS Drug Rev; 2005; 11(1):1-20. PubMed ID: 15867950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers.
    Ferron GM; Paul J; Fruncillo R; Richards L; Knebel N; Getsy J; Troy S
    J Clin Pharmacol; 2002 Feb; 42(2):175-82. PubMed ID: 11831540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the new antiepileptic drug retigabine in a rodent model of mania.
    Dencker D; Dias R; Pedersen ML; Husum H
    Epilepsy Behav; 2008 Jan; 12(1):49-53. PubMed ID: 18086455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In utero exposure to phenobarbital and intelligence deficits in adult men.
    Reinisch JM; Sanders SA; Mortensen EL; Rubin DB
    JAMA; 1995 Nov; 274(19):1518-25. PubMed ID: 7474220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Permanent motor activity and learning disorders induced by exposure to phenytoin during gestation and early infancy in the rat.
    Wolansky MJ; Azcurra JM
    Neurotoxicol Teratol; 2005; 27(2):299-310. PubMed ID: 15734280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of gabapentin on cognitive processes in rats not exposed and exposed to tobacco smoke during fetal life.
    Czubak A; Nowakowska E; Kus K; Sadowski C; Matschay A
    Hum Exp Toxicol; 2008 Dec; 27(12):883-94. PubMed ID: 19273543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urodynamic effects of the K+ channel (KCNQ) opener retigabine in freely moving, conscious rats.
    Streng T; Christoph T; Andersson KE
    J Urol; 2004 Nov; 172(5 Pt 1):2054-8. PubMed ID: 15540788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin potentiates the anticonvulsant action of phenobarbital in neonatal rats.
    Forcelli PA; Soper C; Duckles A; Gale K; Kondratyev A
    Epilepsy Res; 2013 Dec; 107(3):217-23. PubMed ID: 24206906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
    Swiader M; Wielosz M; Czuczwar SJ
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation.
    Dost R; Rostock A; Rundfeldt C
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):382-90. PubMed ID: 15007538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular responses to retigabine in conscious rats--under normotensive and hypertensive conditions.
    Fretwell LV; Woolard J
    Br J Pharmacol; 2013 Jul; 169(6):1279-89. PubMed ID: 23581476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late emerging effects of prenatal and early postnatal nicotine exposure on the cholinergic system and anxiety-like behavior.
    Eppolito AK; Bachus SE; McDonald CG; Meador-Woodruff JH; Smith RF
    Neurotoxicol Teratol; 2010; 32(3):336-45. PubMed ID: 20060465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.